L.R. Sands, M.D. Hellinger,SUMMARY In the United States alone, it is estimated that there will be over 138,000 new cases of colorectal cancer diagnosed and over 50,000 deaths in 2001. This represents the fourth most common malignancy and the second leading cause of cancer death. Surgery remains the mainstay of treatment for this disease. However, it is limited by tumour stage, location and biological behavior. Although curable in its early stages, the ultimate overall survival is no better than 50%. These numbers have remained relatively constant despite screening and attempts at earlier diagnosis. Newer advances in surgical therapy have centered on the management of rectal carcinoma. Laparoscopic surgical techniques have been adapted to surgical resection of the colon, however for malignant processes it still remains investigational.application/pdfhttp://www.annalsgastro.gr/index.php/annalsgastro/article/view/227engHellenic Society of Gastroenterology1792-74631108-7471Annals of Gastroenterology; Volume 16, No 3 (2003)Colorectal Cancer – A surgical approachinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion2007-03-19Δημοσίευση σε περιοδικόPublication in journalΓαστροεντερολογίαGastroenterologyisi -Gastroenterology & Hepatology covers resources on the anatomy, physiology, biochemistry, and pathology of the digestive system. This category includes specific resources on the prognosis and treatment of digestive diseases; stomach ulcers; metabolic, genetic, infectious and chemically induced diseases of the liver; colitis; diseases of the pancreas and diseases of the rectum.Επιστημονικό άρθροScientific articleΕλληνική Γαστροεντερολογική ΕταιρίαGreek Aggregator OpenArchives.gr | National Documentation Centre (EKT)other